Natural killer activity in patients with acute viral hepatitis. 1986

L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi

Using the natural killer (NK) sensitive K562 cell line, enhanced NK cell cytotoxicity was demonstrable early in the course of acute hepatitis B while normal values were obtained in patients studied during convalescence. No evidence of enhanced NK activity was instead obtained in the course of acute non-A, non-B hepatitis. Serum levels of alpha-interferon, as determined by radioimmunoassay (RIA), were significantly increased in patients with acute hepatitis B showing enhanced NK cell activity but not in those with acute non-A, non-B hepatitis and normal NK cell activity. These results suggest that natural cytotoxicity may play a role early in the course of acute hepatitis type B, before antigen-specific T lymphocytes become fully operative.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
December 2008, Journal of viral hepatitis,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
November 2015, Cellular and molecular gastroenterology and hepatology,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
December 1978, Israel journal of medical sciences,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
January 1994, Voprosy virusologii,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
May 2014, The Journal of infectious diseases,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
August 1991, Hepato-gastroenterology,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
January 2000, Likars'ka sprava,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
October 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
September 2010, European journal of clinical investigation,
L Chemello, and M Mondelli, and F Bortolotti, and E Schiavon, and P Pontisso, and A Alberti, and E G Rondanelli, and G Realdi
November 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!